Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71,863 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY, Jung K, Lee JH, Choi JY, Kim NY, Lee H, Kang MR, Kwon MJ, Shin YK, Park YH, Choi YL. Park J, et al. Among authors: park yh. Breast Cancer Res. 2024 Jan 18;26(1):13. doi: 10.1186/s13058-024-01768-y. Breast Cancer Res. 2024. PMID: 38238761 Free PMC article.
Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY, Jung K, Lee JH, Choi JY, Kim NY, Lee H, Kang MR, Kwon MJ, Shin YK, Park YH, Choi YL. Park J, et al. Among authors: park yh. Breast Cancer Res. 2025 Jan 7;27(1):3. doi: 10.1186/s13058-024-01952-0. Breast Cancer Res. 2025. PMID: 39773237 Free PMC article. No abstract available.
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC.
Kim I, Choi SH, Lee SY, Yoo SS, Park JE, Shin KC, Jang JG, Hong KS, Kwon YS, Park SH, Choi KJ, Jung CY, Kim MH, Kim SH, Seol HY, Kim J, Park JH, Kim TH, Eom JS, Ahn JH. Kim I, et al. Among authors: park jh, park je, park sh. Anticancer Res. 2024 Oct;44(10):4505-4516. doi: 10.21873/anticanres.17279. Anticancer Res. 2024. PMID: 39348962
Clinical implication of minimal presence of solid or micropapillary subtype in early-stage lung adenocarcinoma.
Choi SH, Jeong JY, Lee SY, Shin KM, Jeong SY, Park TI, Do YW, Lee EB, Seok Y, Lee WK, Park JE, Park S, Lee YH, Seo H, Yoo SS, Lee J, Cha SI, Kim CH, Park JY. Choi SH, et al. Among authors: park jy, park je, park s, park ti. Thorac Cancer. 2021 Jan;12(2):235-244. doi: 10.1111/1759-7714.13754. Epub 2020 Nov 24. Thorac Cancer. 2021. PMID: 33231358 Free PMC article.
71,863 results
You have reached the last available page of results. Please see the User Guide for more information.